Shragai T, Lavi N, Vaxman I, Gatt ME, Chubar E, Ganzel C, Magen H, Luttwak E, Mittelman M, Trestman S, Lebel E, Saban R, Vainstein V, Zuckerman T, Horowitz N, Tzoran I, Horesh N, Lowenton-Spier N, Melamed N, Pereg I, Avivi I, Cohen YC. Ixazomib, pomalidomide and dexamethasone in triple-class exposed multiple myeloma patients - a phase II study. Haematologica; https://doi.org/10.3324/haematol.2026.301067 [Early view].